171 related articles for article (PubMed ID: 19246639)
21. A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism.
Nakagawa T
Clin Nephrol; 2009 Feb; 71(2):103-9. PubMed ID: 19203501
[TBL] [Abstract][Full Text] [Related]
22. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
Kim SI; Han DC; Lee HB
J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
[TBL] [Abstract][Full Text] [Related]
23. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.
Lassila M; Jandeleit-Dahm K; Seah KK; Smith CM; Calkin AC; Allen TJ; Cooper ME
J Am Soc Nephrol; 2005 Feb; 16(2):363-73. PubMed ID: 15625075
[TBL] [Abstract][Full Text] [Related]
24. Endothelial cell-specific overexpression of endothelial nitric oxide synthase in Ins2Akita mice exacerbates diabetic nephropathy.
Natarajan M; Habib SL; Reddick RL; Delma CR; Manickam K; Prihoda TJ; Werner SL; Mohan S
J Diabetes Complications; 2019 Jan; 33(1):23-32. PubMed ID: 30424931
[TBL] [Abstract][Full Text] [Related]
25. A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy.
Wang CH; Li F; Hiller S; Kim HS; Maeda N; Smithies O; Takahashi N
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):2070-5. PubMed ID: 21245338
[TBL] [Abstract][Full Text] [Related]
26. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
27. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.
Zhao HJ; Wang S; Cheng H; Zhang MZ; Takahashi T; Fogo AB; Breyer MD; Harris RC
J Am Soc Nephrol; 2006 Oct; 17(10):2664-9. PubMed ID: 16971655
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
29. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
Wang S; Denichilo M; Brubaker C; Hirschberg R
Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
[TBL] [Abstract][Full Text] [Related]
30. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.
Takahashi T; Harris RC
J Diabetes Res; 2014; 2014():590541. PubMed ID: 25371905
[TBL] [Abstract][Full Text] [Related]
31. Mouse models of diabetic nephropathy.
Alpers CE; Hudkins KL
Curr Opin Nephrol Hypertens; 2011 May; 20(3):278-84. PubMed ID: 21422926
[TBL] [Abstract][Full Text] [Related]
32. Beneficial effects of C-peptide on renal morphology in diabetic rats.
Sun W; Gao X; Zhao X; Cui D; Xia Q
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
[TBL] [Abstract][Full Text] [Related]
33. Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not to the constitutive defect in endothelial nitric oxide synthase enzyme.
Kubis N; Besnard S; Silvestre JS; Feletou M; Huang PL; Lévy BI; Tedgui A
J Hypertens; 2002 Feb; 20(2):273-80. PubMed ID: 11821712
[TBL] [Abstract][Full Text] [Related]
34. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.
Park CW; Kim HW; Ko SH; Chung HW; Lim SW; Yang CW; Chang YS; Sugawara A; Guan Y; Breyer MD
Diabetes; 2006 Apr; 55(4):885-93. PubMed ID: 16567507
[TBL] [Abstract][Full Text] [Related]
35. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
36. Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney.
Nakayama T; Sato W; Yoshimura A; Zhang L; Kosugi T; Campbell-Thompson M; Kojima H; Croker BP; Nakagawa T
Am J Pathol; 2010 May; 176(5):2198-208. PubMed ID: 20363914
[TBL] [Abstract][Full Text] [Related]
37. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.
Fan Q; Liao J; Kobayashi M; Yamashita M; Gu L; Gohda T; Suzuki Y; Wang LN; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2004 Dec; 19(12):3012-20. PubMed ID: 15574998
[TBL] [Abstract][Full Text] [Related]
38. Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse.
Ozawa S; Ueda S; Li Y; Mori K; Asanuma K; Yanagita M; Nakagawa T
Biochem Biophys Res Commun; 2014 Nov; 454(4):531-6. PubMed ID: 25450688
[TBL] [Abstract][Full Text] [Related]
39. ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice.
Tesch GH; Ma FY; Han Y; Liles JT; Breckenridge DG; Nikolic-Paterson DJ
Diabetes; 2015 Nov; 64(11):3903-13. PubMed ID: 26180085
[TBL] [Abstract][Full Text] [Related]
40. NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney.
Zhu K; Kakehi T; Matsumoto M; Iwata K; Ibi M; Ohshima Y; Zhang J; Liu J; Wen X; Taye A; Fan C; Katsuyama M; Sharma K; Yabe-Nishimura C
Free Radic Biol Med; 2015 Jun; 83():21-30. PubMed ID: 25701431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
